Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe record history now includes a new revision on 2026-07-31 that adds the Contacts/Locations and Study Status sections (associated with version 211), following an earlier 2026-07-30 entry. A deletion dated 2026-05-14 is also reflected in the history.SummaryDifference0.1%

- Check9 days agoChange DetectedA new page revision entry, v3.6.4, was added to the history. The previous revision, v3.6.3, was removed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe history now includes a new Revision: v3.6.3 entry, updating the page to the latest revision and replacing the previous v3.6.2 entry.SummaryDifference0.0%

- Check38 days agoChange DetectedThe footer revision label was updated from v3.6.0 to v3.6.2, indicating a newer site revision. No study data or functionality changes are evident.SummaryDifference0.0%

- Check52 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'. A new Revision: v3.6.0 entry was added and the previous Revision: v3.5.5 entry was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label in the page footer updated from v3.5.4 to v3.5.5. This reflects a newer site revision.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.